UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

 

Date of Report (date of earliest event reported): January 11, 2016

 

 

Natus Medical Incorporated

(Exact name of registrant as specified in its charter)

 

000-33001

(Commission File Number)

 

     
Delaware   77-0154833

(State or other jurisdiction

of Incorporation)

 

  

(I.R.S. Employer

Identification No.)

 

6701 Koll Center Parkway, Suite 120

Pleasanton, CA 94566

(Address of principal executive offices)

 

925-223-6700

(Registrant’s telephone number, including area code)

 

 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

 

 

  [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

Item 2.02. Results of Operations and Financial Condition

 

On January 11, 2016, Natus Medical Incorporated (the "Company") is issuing a press release regarding 2016 annual and first quarter financial guidance including fourth quarter and full year 2015 revenue estimates. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information in this Item 2.02 and the exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Item 9.01. Financial Statements and Exhibits

 

(d) Exhibits.

  

Exhibit No.   Description
99.1   Press release dated January 11, 2016 describing the Company's 2016 annual and first quarter financial guidance and other financial information.

 

 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

       

NATUS MEDICAL INCORPORATED

(Registrant)

 

       
Dated: January 11, 2016       By:  /s/ Jonathan A. Kennedy
        Senior Vice President Finance and Chief Financial Officer

 

 

 

 

 

Exhibit Index

 

 

Exhibit No.   Description
99.1   Press release dated January 11, 2016 describing the Company's 2016 annual and first quarter financial guidance and other financial information.